Search

Displaying results 9171 - 9180 of 10000 in total

Drug
Triheptanoin
go.drugbank.com/drugs/DB11677
ApprovedInvestigational
Triheptanoin is a source of heptanoate fatty acids, which can be metabolized without the enzymes of long chain fatty acid oxidation.
Drug
Benfotiamine
go.drugbank.com/drugs/DB11748
ApprovedInvestigationalWithdrawn
Benfotiamine has been investigated for the treatment and prevention of Diabetic Nephropathy and Diabetes Mellitus, Type 2.
Categories: Compounds used in a research, industrial, or household setting
Drug
Anisodamine
go.drugbank.com/drugs/DB11785
Investigational
Anisodamine has been investigated for the treatment of Intestinal Diseases.
Categories: Compounds used in a research, industrial, or household setting, Cytochrome P-450 Substrates
Drug
Mirodenafil
go.drugbank.com/drugs/DB11792
Investigational
Mirodenafil has been used in trials studying the treatment and supportive care of Kidney Diseases, Urologic Diseases, Renal Insufficiency, Erectile Dysfunction, and Male Erectile Dysfunction.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
Drug
Saracatinib
go.drugbank.com/drugs/DB11805
Investigational
Saracatinib has been investigated for the treatment of Cancer, Osteosarcoma, Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer.
Categories: Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors
Drug
Dinitrochlorobenzene
go.drugbank.com/drugs/DB11831
Investigational
Dinitrochlorobenzene has been used in trials studying the treatment of HIV Infections.
Categories: Compounds used in a research, industrial, or household setting
Drug
Carboxyamidotriazole
go.drugbank.com/drugs/DB11960
Investigational
Carboxyamidotriazole has been used in trials studying the treatment of Lymphoma, Lung Cancer, Breast Cancer, Kidney Cancer, and Ovarian Cancer, among others.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
Drug
GDC-0623
go.drugbank.com/drugs/DB11982
Investigational
GDC-0623 has been used in trials studying the treatment of Solid Cancers.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C19 Substrates
Drug
Benznidazole
go.drugbank.com/drugs/DB11989
ApprovedInvestigational
Benznidazole was granted accelerated approval for the treatment of Chagas disease in children 2-12 years of age by the FDA on August 29, 2017. It is the first treatment made available in the United States for Chagas disease.
Categories: P-glycoprotein substrates, Cytochrome P-450 Substrates
Drug
2-octyl cyanoacrylate
go.drugbank.com/drugs/DB12040
Investigational
Dermabond has been investigated for the basic science of Wound Healing.
Categories: Compounds used in a research, industrial, or household setting